Investment
Features
FeesSafety
Academy
More
Pluang+

Gradient Investments increases stake in Vertex Pharmaceuticals to $19.76M, amid strong analyst buy ratings.

Market News
23 Mar 2026
Defense World
View Source
Neutral
pluang ai news

Gradient Investments LLC raised its holdings in Vertex Pharmaceuticals by 6.4% in Q4, now owning shares worth $19.76 million. Vertex, a biotech leader known for cystic fibrosis treatments, reported solid revenue growth and slightly missed EPS estimates in its recent quarter. Analysts remain optimistic, with multiple firms raising price targets and maintaining buy ratings. Insider selling occurred but institutional ownership remains high at over 90%.

More News (VRTX)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App